PANoptosis-Related Diagnostic Biomarkers in Non-Neovascular Age-Related Macular Degeneration: An Integrative Transcriptomic and Experimental Study. [PDF]
Li J +7 more
europepmc +1 more source
Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. [PDF]
Tillmann A +21 more
europepmc +1 more source
Evolution of Anti-Vascular Endothelial Growth Factor Clinical Trial Design for Treating Neovascular Age-Related Macular Degeneration. [PDF]
Klufas MA +3 more
europepmc +1 more source
Reducing the Carbon Footprint of Neovascular Age-Related Macular Degeneration Therapy: Environmental Impact of Transitioning to Aflibercept 8 mg. [PDF]
Veritti D +9 more
europepmc +1 more source
Refractory Neovascular Age-related Macular Degeneration
Dae Joong Ma, Hyeong Gon Yu
openaire +2 more sources
Age-Specific Increases in the Prevalence and Treatment Burden of Neovascular Age-Related Macular Degeneration in a Super-Aged Society. [PDF]
Akada M +9 more
europepmc +1 more source
Early detection of age related macular degeneration: current status [PDF]
core +1 more source
Targeted Fluorescence Imaging of Bevacizumab-800CW in Patients with Neovascular Age-Related Macular Degeneration. [PDF]
Schmidt I +6 more
europepmc +1 more source
Efficacy of brolucizumab and ranibizumab in diabetic macular edema and neovascular age-related macular degeneration: insights from a case series. [PDF]
Hossain B, Rahmatullah S, Ahmed T.
europepmc +1 more source
Massive Submacular Hemorrhage Following Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration. [PDF]
Kaganovski A, Rostomian N, Shrier E.
europepmc +1 more source

